Page last updated: 2024-09-03

cci 103f and Cancer of Pituitary

cci 103f has been researched along with Cancer of Pituitary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashcroft, M; Baker, LC; Boult, JK; Burrell, JS; Gilmour, LD; Griffiths, JR; Howe, FA; Jamin, Y; Raleigh, JA; Robinson, SP; van der Kogel, AJ; Walker-Samuel, S	1

Other Studies

1 other study(ies) available for cci 103f and Cancer of Pituitary

Article	Year
Evaluation and immunohistochemical qualification of carbogen-induced ΔR₂ as a noninvasive imaging biomarker of improved tumor oxygenation. International journal of radiation oncology, biology, physics, 2013, Sep-01, Volume: 87, Issue:1 Topics: Animals; Biomarkers; Carbon Dioxide; Cell Hypoxia; Immunohistochemistry; Magnetic Resonance Imaging; Mice; Nitroimidazoles; Oxygen; Oxygen Consumption; Partial Pressure; Pituitary Neoplasms; Prolactinoma	2013

Article

Year

Evaluation and immunohistochemical qualification of carbogen-induced ΔR₂ as a noninvasive imaging biomarker of improved tumor oxygenation.

International journal of radiation oncology, biology, physics, 2013, Sep-01, Volume: 87, Issue:1

Topics: Animals; Biomarkers; Carbon Dioxide; Cell Hypoxia; Immunohistochemistry; Magnetic Resonance Imaging; Mice; Nitroimidazoles; Oxygen; Oxygen Consumption; Partial Pressure; Pituitary Neoplasms; Prolactinoma

2013